Clinical Trial Update: Intravenous Methylene Blue for Treating Refractory Neonatal Septic Shock [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial evaluating intravenous methylene blue for refractory neonatal septic shock, currently in Phase 2/Phase 3 and not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Sepsis
• Septic Shock

Drugs mentioned

• METHYLENE BLUE (METHYLENE BLUE)

Snippet

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: Neonatal Sepsis, Shock, Septic | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING